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Abstract Labeling of cells with nanoparticles for living
detection is of interest to various biomedical applications.
In this study, novel ﬂuorescent/magnetic nanoparticles
were prepared and used in high-efﬁcient cellular imaging.
The nanoparticles coated with the modiﬁed chitosan pos-
sessed a magnetic oxide core and a covalently attached
ﬂuorescent dye. We evaluated the feasibility and efﬁciency
in labeling cancer cells (SMMC-7721) with the nanopar-
ticles. The nanoparticles exhibited a high afﬁnity to cells,
which was demonstrated by ﬂow cytometry and magnetic
resonance imaging. The results showed that cell-labeling
efﬁciency of the nanoparticles was dependent on the
incubation time and nanoparticles’ concentration. The
minimum detected number of labeled cells was around 10
4
by using a clinical 1.5-T MRI imager. Fluorescence and
transmission electron microscopy instruments were used to
monitor the localization patterns of the magnetic nano-
particles in cells. These new magneto-ﬂuorescent
nanoagents have demonstrated the potential for future
medical use.
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Introduction
Magnetic iron oxide nanoparticles (MIONPs) have been
extensively utilized for drug delivery, magnetic resonance
imaging (MRI), hyperthermia techniques, cell separation,
and tissue repair [1–5]. Especially, when used as a contrast
agent for the MRI, MIONPs allow researchers and clini-
cians to enhance the tissue contrast of an area of interest by
increasing the relaxation rate of water. Although native
MIONPs appear to be the currently preferred cell-labeling
materials, the relatively poor signal intensity of MIONPs
on MRI limits their clinical utility. Hence, more efﬁcient
cellular-internalizing methods are highly preferable.
Recent studies on the size effect [6, 7], surface chemistry
[8, 9], targeting ligands [10], and assemblies of MIONPs
under magnetic ﬁeld [11] have been reported to improve
the internalization of the contrast agent. However, the
internalizing efﬁciency is still generally low as manifested
by the requirement of a long-term incubation or a high
concentration of particles with cells.
The stabilized MNPs in aqueous solutions are promising
candidates for biomedical applications. One possible way
is to encapsulate them with polymeric materials. Ideally,
this polymeric material should be biocompatible and pos-
sess reactive functional groups for the further attachment of
biomolecules. Chitosan is a natural poly-cationic polymer
that has one amino group and two hydroxyl groups in the
repeating hexosaminide residue. It is an ideal polymer in
biological applications owing to their being hydrophilic,
biocompatible, biodegradable, non-antigenic and nontoxic
[12, 13]. In addition, chitosan is known to facilitate drug
delivery across cellular barriers and transiently open the
tight junctions between epithelial cells [14].
Fabrication of magnetic and optical imaging into a
nanostructured system would greatly beneﬁt in disease
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[15–17]. Fluorescent dye molecules and quantum dots
(QDs) are most predominantly used for biological staining
and optical labeling [18–23]. Considerable research has
been devoted to the combination of magnetic and ﬂuores-
cent properties in a single nanocomposite, which could act
as multi-targeting, multi-functional, and multi-treating
tools. However, the synthetic procedure in previous studies
requires the multi-step chemical treatments. Thus, we syn-
thesize a simple and stable nanoprobe that exhibits
magnetic and ﬂuorescence properties for detection of can-
cer cell. The chemical synthesis is based on the covalent
coupling of modiﬁed organic ﬂuorophores with chitosan,
which strongly interact with the surface of the ferric oxide
nanoparticles (Fig. 1). The high cellular afﬁnity and imag-
ing efﬁcacy of the nanoparticles have extensively been
investigated using MRI and optical imaging.
Experiments
Preparation and Characterization of FITC-Labeled
Chitosan Nanoparticles
The synthesis of FITC-labeled chitosan was based on the
reaction between the isothiocyanate group of FITC and the
primary amino group of chitosan [24]. The FITC of 20 mg
in 20 ml dehydrated methanol was added to 20 ml 1% w/v
chitosan (low molecular, Sigma-Aldrich.) in 0.1 M acetic
acid solution. After 3 h of reaction in the dark at ambient
temperature, the FITC-labeled chitosan (FITC-CS) was
precipitated by raising the pH to 10 with 0.5 M NaOH. The
unreacted FITC was washed with distilled water and sepa-
rated by centrifuge until no ﬂuorescence was detected in the
suspernatant. The FITC-CS dissolved in 20 ml 0.1 M acetic
acid was then dialyzed in 4 l of distilled water for 3 days
under darkness, with water being replaced every day.
Fe3O4 nanoparticles were synthesized by chemical
coprecipitation of Molday. In typical synthesis, a mixture
solution of FeCl3 and FeSO4 (molar ratio 2:1) was prepared
under N2 shielding and then enough ammonia aqueous
solution was poured into it while violently stirring. The
black precipitate was formed and washed several times with
deionized water. The ﬁnal magnetite nanoparticles were
dispersed in deionized water with pH 3.0 and oxidized into
more stable maghemite (c-Fe2O3, MNPs) by air at the
temperature of 90C. During this step, the initial black
slurry turning into brown could be observed [25]. After that,
MNPs were coated with FITC-CS (FITC-CS@MNPs), and
4 ml of above FITC-CS acetic acid solution was added to
50 ml of MNPs solution. The mixture was stirred for 4 h
and then washed by the above magnetic separation method
to remove dissociative FITC-CS.
Characterization of Magnetic Particles
The magnetic measurements were carried out using a
Vibrating Sample Magnetometer (VSM, Lakeshore 7407,
USA). The zeta potentials of the particles were determined
by Zeta Potential Analyzer (BECKMAN, Delsa 440SX,
USA). The particle morphology and size of the samples
were determined by transmission electronic microscopy
(TEM, JEOL, JEM-200EX). The emission spectra were
measured with a Hitachi FL4500. The emission absorption
spectra were measured using a LS-55 spectrophotometer
(PerkinElmer, USA).
Cell Culture
Human hepatoma cell line, SMMC-7721, was provided by
Shanghai Cellular Institute of China Scientiﬁc Academy.
Cells were cultured in RPMI 1640 medium containing 10%
fetal calf serum (FCS), 100 lg/ml penicillin, and 100 lg/ml
streptomycin. For control experiments, medium having no
particle was used. The cells were incubated at 37Ci n5 %
CO2 atmosphere and medium was replaced every other day.
Cellular Uptake Experiments
In the cell-uptake experiments, the cells were incubated
with different concentrations of FITC-CS@MNPs suspen-
sion in medium for various incubation times. After
Fig. 1 Schematic diagram of preparation of FITC-CS@MNPs
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123indicated times, the cells were washed three times with
0.1 M PBS, then harvested by trypsinization, centrifuged,
and resuspended in 0.1 M PBS or 0.5 ml of 1% agarose in
Eppendorf tubes. Cellular uptake of FITC-CS@MNPs was
determined semiquantitatively by the incorporated ﬂuo-
rescence intensity and MR functionalities, using a BD
FACS Calibur ﬂow cytometry (BD Biosciences, Franklin
Lakes, NJ, USA) and a clinical 1.5-T MRI System
(Eclipse, Philips Medical Systems, The Netherlands) by
using a 12.7-cm receive-only surface coil, respectively.
The ﬂuorescence of NBD- labeled green marker com-
pounds was measured with a 488-nm argon laser excitation
and a 530/30 bandpass ﬁlter for emissions. The whole
amounts of cell surface uptake level and the intracellular
uptake level were qualiﬁed by converting to an average
number of molecules per cell.
The sequence parameters for T1-weighted (T1 W)
imaging was spin-echo repetition time 500 ms, echo time
17.9 ms; T2-weighted (T2 W) imaging was fast spin-echo
repetition time 4000 ms; echo time 108 ms; echo train
length 16; T2*-weighted (T2*W) imaging was gradient-
echo repetition time 620 ms, echo time 15.7 ms; ﬂip angle
35. Images were obtained with a matrix size of
256 9 256—two measurements were acquired: section
thickness of 2 mm; ﬁeld of view of 10 9 10 cm. Region of
interest for signal intensity measurement was 20 mm
2.
These tubes contained 5 9 10
2,1 9 10
3,5 9 10
3,
1 9 10
4,5 9 10
4,1 9 10
5 labeled cells, respectively.
Another two Eppendorf tubes containing 1 9 10
6 unla-
beled cells and distilled water were used.
Fluorescent and Transmission Electron Microscopy
After magnetic nanoparticles labeling, adhering cells were
washed three times with 0.1 M PBS and then ﬁxed with 2%
glutaraldehyde buffered in 0.1 M PBS for 1 h at 4C. The
optical and ﬂuorescent images were observed with an
Axioskop 200 microscope equipped with a Coolsnap
MP3.3 camera (Carl Zeiss, Germany).
For the samples of TEM, the cells were washed three
times with 0.1 M PBS, then harvested by trypsinization,
centrifuged, and ﬁxed with 2% glutaraldehyde buffered in
0.1 M PBS for 1 h at 4C. The cells were then post-ﬁxed in
1% osmium tetroxide for 2 h at 4C, washed again with
PBS, dehydrated through a series of alcohol concentrations
(20, 30, 40, 50, 60, 70%), and followed by further dehy-
dration(90, 96, 100% and dry alcohol). The cells were
ﬁnally treated with propylene oxide followed by 1:1 pro-
pylene oxide: resin for overnight to evaporate the
propylene oxide. The cells were subsequently embedded in
Araldite resin, and ultra-thin sections cut with glass knives
were stained with lead nitrate, and viewed under a
HITACHIH-600 electron microscope at 80 kV.
In Vitro Cell-Viability/Cytotoxicity Studies
To determine cell cytotoxicity/viability, the cells were
plated at a density of 1 9 10
4 cells/well in 96-well plates at
37Ci n5 %C O 2 atmosphere. After 24 h of culture, the
medium in the wells was replaced with the fresh medium
containing nanoparticles in the concentration range of
0–123.52 lg/ml. After 12 h, the medium was removed and
rinsed twice with medium, and then 20 ll of MTT (3,4,5-
dimethylthiazol-yl-2,5-diphenyl tetrazolium, Sigma) dye
solution (5 mg/ml in medium) was added to each well.
After 4 h of incubation at 37C, the medium was removed,
and Formazan crystals were dissolved in 200 ll dimeth-
ylsulphoxide (DMSO) and quantiﬁed by measuring the
absorbance of the solution at 570 nm by a microplate
reader (Model 680, Bio-RAD). The spectrophotometer was
calibrated to zero absorbance, using culture medium
without cells. The relative cell viability (%) related to
control wells containing cell culture medium without
nanoparticles was calculated by [A]test/[A]control 9 100,
where [A]test is the absorbance of the test sample and
[A]control is the absorbance of control sample.
Statistical Analysis
Each experiment was repeated three times in duplicate. The
results were presented as mean ± SD. Statistical signiﬁ-
cance was accepted at a level of P\0.05.
Results and Discussion
Characterize of FITC-CS@MNPs
A representative hysteresis loop of FITC-CS@MNPs at
ambient temperature is shown in Fig. 2. The saturation
magnetization of the FITC-CS@MNPs was about
Fig. 2 Magnetization curves of naked MNPs and FITC-CS@MNPs
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12353.47 emu/g, while that of naked MNPs was about
55.52 emu/g. The decrease of the saturation magnetization
was most likely attributed to the existence of coated
materials on the surface of MNPs.
The electrostatic interaction of the nanoparticles can be
controlled by variation in their surface charges, which can
be determined by measuring the zeta potential of these
particles. Figure 3 illustrated the zeta potential of naked
MNPs and FITC-CS@MNPs as a function of pH. It
showed that the zeta potential of naked MNPs and FITC-
CS@MNPs was positive at lower pH and negative at
higher pH [26]. Compared with naked MNPs, the zeta
potential of FITC-CS@MNPs possessed higher positive
charge at physiological environment (pH = 7.4), which
favored the association to the negative domain of cell
membrane. IEP of FITC-CS@MNPs was about 9.7 where
the net charge of surface is zero.
The size and morphology of the FITC-CS@MNPs were
investigated by TEM (Fig. 4a). The particle size and size
distribution of these particles were calculated with at least
200 particles chosen at random in all the prepared samples
through an image analysis program. Most of FITC-
CS@MNPs were quasispherical and with an average
diameter of 13.8 ± 5.3 nm. The nanoparticles can form a
stable dispersion in neutral water for several months
without noticeable precipitation. The electron-diffraction
pattern recorded from these spheres conﬁrmed that mag-
netite nanoparticles were coated successfully. A salient
feature of Fig. 4c is that these nanoparticles have an
intense dark circle within the shells of the spheres and dark
spots at the surface of some spheres, which suggests that
the distribution of the c-Fe2O3 nanoparticles is not con-
centrated in the core of the spheres, which corresponds well
to the size of the used c-Fe2O3 nanoparticles.
The ﬂuorescent properties of FITC-CS@MNPs were
investigated with the excitation peak in 488 nm. As can be
seen from Fig. 5, the FITC-CS@MNPs exhibited an
intense and narrow emission spectrum with a peak at
520 nm, similar to that of FITC with a peak at 518 nm
(Fig. 5). The small red-shift (2 nm) resulted from the sur-
rounding environments of the amino groups or the
interaction between the dye and the oxide nanoparticles,
which was also reported in previous studies [23]. The
Fig. 3 pH-dependent zeta potential curves of naked MNPs and
FITC-CS@MNPs
Fig. 4 TEM images of (a) FITC-CS@MNPs, (b) mean
size = 13.8 ± 5.3 nm, and (c) Electron-diffraction pattern of FITC-
CS@MNPs
Fig. 5 Emission spectra (kex = 488 nm) of FITC, FITC-CS, and
FITC-CS@MNPs
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123ﬂuorescence intensity of the FITC-CS@MNPs was lower
than that of FITC-CS. This may be due to the quenching
when ﬂuorescence contacted MNPs surface and the pos-
sible energy transfer occurring with metal oxide particles.
Nevertheless, there was still sufﬁcient emission for bio-
logical imaging. The strong and stable ﬂuorescence of the
FITC-CS@MNPs provided a visual detection method for
cell labeling and monitoring their location in body.
Cellular Uptake
To examine the cell-labeling efﬁciency, SMMC-7721
cells were incubated with various concentrations of
FITC-CS@MNPs for 2 h and different labeling times of
FITC-CS@MNPs (15.44 lg). In control experiments,
medium having no particle was used. We found FITC-
CS@MNPs uptake was dose- (1.93, 3.86, 7.72, 15.44, and
30.88 lg) and time-(0.5, 1, 2, 4, and 8 h) dependent. In the
ﬂow cytometry data (Fig. 6), the histograms of ﬂuores-
cence intensity of cells that were incubated with various
concentrations of FITC-CS@MNPs for 2 h were displayed,
and data showed that the number of labeled cells and the
mean value of ﬂuorescence intensity followed the incuba-
tion concentration of FITC-CS@MNPs. When the FITC-
CS@MNPs (7.72 lg) were incubated with the cells, more
than 85% of cells were labeled. As shown in the Fig. 7, the
Fig. 6 Flow cytometric
analysis of SMMC-7721 cells
when incubated with different
dosages (1.93 lg( b), 3.86 lg
(c), 7.72 lg( d), 15.44 lg( e)
and 30.88 lg( f)) of FITC-
CS@MNPs. In control
experiments, medium having no
particle was used (a). The mean
ﬂuorescence intensity of FITC-
CS@MNPs labeled cells was
noted below the line and the
percentage of labeled cells was
noted above the line. The
number of positively labeling
cells (deﬁned as the
ﬂuorescence value[10
1) was
represented as the percentage of
total counting cells in each
panel. The histogram showed
that there was the percentage of
labeled cells under different
dosage of FITC-CS@MNPs
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123uptake of FITC-CS@MNPs began signiﬁcantly as early as
30 min after incubation with 15.44 lg of nanoparticles,
and was relatively more rapid within the ﬁrst 2 h of incu-
bation. As time elapsed, it became a cumulative process.
This indicated cells can be labeled efﬁciently within a short
incubation time by using a relatively low dose of FITC-
CS@MNPs.
Using a clinical 1.5-T MR imager, the MR images of
samples in Eppendorf tubes were detected. Under T2*
weighted image mode (T2*WI), cells exposed to 15.44 lg
of FITC-CS@MNPs for 2 h could be easily detected
(Fig. 8). These MRI measurements were consistent with
the results obtained through ﬂow cytometry studies. It
implied that through the high cellular labeling efﬁciency of
FITC-CS@MNPs, a small number of SMMC-7721 was
easily imaged with a short-term incubation using a clinical
1.5-T MR imager. To investigate the limit of labeling, a
series of diluted labeled cells were investigated for MRI.
Figure 7 showed the MR images of FITC-CS@MNPs
could be distinguishably observed at the cell numbers of
around 10
4. The minimum number of cells detected was
around 5 9 10
3 to 1 9 10
4. No signal intensity difference
was observed from the unlabeled control group. It was
reported that the SPIO@SiO2(FITC) nanoparticles could
detect about 1 9 10
4 cells after treatment with 30 lg/ml
nanoparticles for 1 h under 1.5-T MR imager [27]. And,
Fig. 7 Flow cytometric
analysis of SMMC-7721 cells
when incubated with FITC-
CS@MNPs for a deﬁnite time
(0.5 h (b) ,1h( c) ,2h( d), 4 h
(e), 8 h (f)). In control
experiments, medium having no
particle was used (a). The mean
ﬂuorescence intensity of FITC-
CS@MNPs labeled cells was
noted below the line and the
percentage of labeled cells was
noted above the line. The
number of positively labeling
cells (deﬁned as the
ﬂuorescence value[10
1) was
represented as the percentage of
total count of the cells in each
panel. The histogram showed
the percentage of labeled cells
when treated with FITC-
CS@MNPs for a deﬁnite time
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123labeling of the human umbilical cord blood mesenchymal
stem cells (MSCs) with 20 lg/ml poly-l-lysine@SPIO,
T2*WI demonstrated signiﬁcant decrease of signal inten-
sity in vials containing 1 9 10
6 (1 day), 1 9 10
6 (8 days),
and 5 9 10
5 labeled cells, in comparison with the unla-
beled cells to obtain MRI of the labeled MSCs’ suspension
at 1.5 T [28]. Thus the FITC-CS@MNPs had high cellular
afﬁnity and low detection threshold of cell number.
In order to clarify the location of the magnetic nanopar-
ticles in the cells, we performed ﬂuorescence microscopy
and electron microscopy. We observed that the magnetic
particles were located inside the cells as well as on the cell
surface (Fig. 9). Hence, binding a ﬂuorescent dye onto
magnetic nanoparticles enabled their direct imaging and
localization in living cells. TEM provided an even higher
resolution than optical imaging. Nanoparticles were inter-
nalized within the cell inside late endosomes or lysosomes
(Fig. 10). Particles were exclusively present in the form of
agglomerates. No uptake into endoplasmatic reticulum,
mitochondria and structures of the Golgi organ or the
nucleus was found. The accumulation of coated particles
within lysosomes was also described by others [29, 30].
Chitosan, which has a positive zeta potential, can
interact with negative domain of cell membranes by non-
speciﬁc electrostatic interactions [13, 14]. FITC-
CS@MNPs, with their tiny size and positive surface
charge, showed a high electrostatic afﬁnity for the cell
membrane. Cellular internalization was initiated by non-
speciﬁc interactions between nanoparticles and cell
membranes. It was reported that A549 cell uptake of
chitosan nanoparticles occurred predominantly by adsorp-
tive endocytosis, mediated in part by clathrin, but not by
passive diffusion or by ﬂuid-phase endocytosis [9]. Cellu-
lar uptake of N-acetyl histidine-conjugated glycol chitosan
self-assembled nanoparticles also was reported to inter-
nalize by adsorptive endocytosis [31]. There were no
reports of chitosan-speciﬁc receptors on cell membranes.
In Vitro Cell-Viability and Cytotoxicity Studies
To evaluate the biocompatibility of FITC-CS@MNPs as
imaging probes, we investigated the cytotoxicity of
Fig. 8 T2* imaging of different number cells when labeled with
FITC-CS@MNPs in vitro. Cells ranging from 5 9 10
2 to 1 9 10
5
after treatment with 15.44 lg FITC-CS@MNP for 2 h were scanned.
Unlabeled cells of identical numbers and distilled water were scanned
as a control group
Fig. 9 Fluorescent images of SMMC-7721 cells when incubated with
(a) Control; (b), (c) FITS-CS@MNPs for 8 h
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123FITC-CS@MNPs using the MTT assay. The MTT assay
relies on the mitochondrial activity of cells and represents a
parameter for their metabolic activity. Figure 11 demon-
strates a dose-dependent reduction in MTT absorbance for
cells treated with FITC-CS@MNPs and naked MNPs.
After having been incubated for 12 h, FITC-CS@MNPs
caused a minor reduction (about 10% of control) in cell
viability and exhibited low cytotoxicity towards SMMC-
7721 even at high dose (123.52 lg). Naked MNPs caused a
signiﬁcant reduction (90% of control) in cell viability even
when tested at the lowest concentration (0.01 mg/ml), and
induced further reductions at higher concentrations; it
resulted in about 65% loss of cell viability when tested at
the higher concentration (0.16 mg/ml). Y. Wang [32] and
A. K. Gupta [33] et al. had investigated the cell viability of
Resovist (commercial iron oxides) and uncoated iron oxide
nanoparticles, respectively. Both these nanoparticles
caused a signiﬁcant reduction in cell viability even when
tested at the lowest concentration tested. It seemed that our
magnetite nanoparticles were highly biocompatible and
safe for further in vivo use.
Conclusions
A novel magnetic ﬂuorescent nanoparticle was prepared by
a simple synthesis method and used for high-efﬁcient
labeling cancer cell. The FITC-CS@MNPs described here
could be efﬁciently internalized into SMMC-7721 because
of their electrostatic interactions with the cell membrane.
These labeled cells can be visualized in a clinical 1.5-T
MRI imager with detectable cell numbers of about 10
4 in
vitro. Magnetic ﬂuorescent nanoparticles serve both as
magnetic resonance contrast agents for MRI and optical
probes for intravital ﬂuorescence microscopy. Cytotoxicity
test demonstrated that the prepared FITC-CS@MNPs
possessed a suitable property for biomedical application.
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